Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 73 (3) , 277-283
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- FDG PET in the management of lymphoma: a clinical perspectiveEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)Radiotherapy and Oncology, 2002
- Incorporating functiona imaging, information into radiation treatmentSeminars in Radiation Oncology, 2001
- Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?European Journal of Nuclear Medicine and Molecular Imaging, 2000
- Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan ImagingBlood, 1999
- Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaNuclear Medicine Communications, 1998
- Attenuation correction for a combined 3D PET/CT scannerMedical Physics, 1998
- Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphomaBlood, 1992
- Survival in Hodgkin's disease by stage and ageMedical and Pediatric Oncology, 1992